| Literature DB >> 36204611 |
Andrei V Gannesen1, Rustam H Ziganshin2, Evelina L Zdorovenko3, Alena I Klimko4, Elena A Ianutsevich1, Olga A Danilova1, Vera M Tereshina1, Maxim V Gorbachevskii5, Maria A Ovcharova1, Ekaterina D Nevolina1, Sergey V Martyanov1, Alexander S Shashkov3, Andrey S Dmitrenok3, Andrei A Novikov5, Marina V Zhurina1, Ekaterina A Botchkova1,5, Philipp V Toukach3, Vladimir K Plakunov1.
Abstract
The importance of the impact of human hormones on commensal microbiota and microbial biofilms is established in lots of studies. In the present investigation, we continued and extended the research of epinephrine effects on the skin commensal Micrococcus luteus C01 and its biofilms, and also the matrix changes during the biofilm growth. Epinephrine in concentration 4.9 × 10-9 M which is close to normal blood plasma level increased the amount of polysaccharides and extracellular DNA in the matrix, changed extensively its protein, lipid and polysaccharide composition. The Ef-Tu factor was one of the most abundant proteins in the matrix and its amount increased in the presence of the hormone. One of the glucose-mannose polysaccharide was absent in the matrix in presence of epinephrine after 24 h of incubation. The matrix phospholipids were also eradicated by the addition of the hormone. Hence, epinephrine has a great impact on the M. luteus biofilms and their matrix composition, and this fact opens wide perspectives for the future research.Entities:
Keywords: Micrococcus luteus; NMR; biofilm matrix; biofilms; epinephrine; host–microbiota interactions; human skin microbiota; mass spectrometry
Year: 2022 PMID: 36204611 PMCID: PMC9530943 DOI: 10.3389/fmicb.2022.1003942
Source DB: PubMed Journal: Front Microbiol ISSN: 1664-302X Impact factor: 6.064
FIGURE 1CsCl gradient formation and biofilm matrix following extraction after 72 h of incubation.
FIGURE 2Differences in the dynamics of the LDH reaction measured in the biofilm cell biomass and matrix samples. (A) Samples after 24 h of incubation. (B) Samples after 72 h of incubation.
Biochemical composition of M. luteus C01 matrix in the presence of epinephrine and in control samples.
| Absolute meanings, μg/g | Sugars | Proteins | DNA | TOC | |||||
|
|
|
|
| ||||||
| 24 h | 72 h | 24 h | 72 h | 24 h | 72 h | 24 h | 72 h | ||
| Upper phase | Control | 1380.9 ± 207.6 | 1401.8 ± 242.4 | 337.3 ± 33.9 | 196 ± 30.1 | 122.2 ± 40.6 | 107.4 ± 22 | 1945 ± 678 | 2340.5 ± 221.5 |
| Epinephrine | 1446.7 ± 316.3 | 1692.1 ± 219.5 | 319 ± 32 | 224.2 ± 37.3 | 104.6 ± 23.6 | 137 ± 22.2 | 2121.1 ± 620 | 3174.8 ± 384.3 | |
| Lower phase | Control | 381.8 ± 67 | 410.2 ± 85.8 | 70.6 ± 11.8 | 49.9 ± 10.2 | 20.9 ± 3.3 | 17.5 ± 0.8 | 325.6 ± 58.2 | 563.4 ± 75.2 |
| Epinephrine | 440 ± 141 | 406.8 ± 133.8 | 80.4 ± 11.7 | 52.2 ± 14.6 | 27.9 ± 7 | 12.7 ± 0.8 | 517.7 ± 162 | 530.1 ± 198.6 | |
| Total matrix | Control | 1762.6 ± 254 | 1811.9 ± 314.5 | 407.9 ± 26 | 245.9 ± 30.3 | 143.1 ± 42.2 | 125 ± 21.5 | 2270.6 ± 693.7 | 2903.9 ± 233.2 |
| Epinephrine | 1887.1 ± 407 | 2180.7 ± 343.6 | 399.4 ± 26 | 276.4 ± 44.7 | 132.4 ± 27.7 | 149.7 ± 22.8 | 2638.8 ± 768.8 | 3704.9 ± 384.3 | |
|
| |||||||||
| Upper phase | Control | 28.4 ± 4.3 | 23.9 ± 4.1 | 7.8 ± 0.8 | 3.8 ± 0.6 | 2 ± 0.7 | 1.5 ± 0.3 | 100 ± 34.8 | 100 ± 9.5 |
| Epinephrine | 27.3 ± 6 | 21.3 ± 2.8 | 6.8 ± 0.7 | 3.2 ± 0.5 | 1.7 ± 0.4 | 1.4 ± 0.2 | 109.1 ± 31.9 | 135.6 ± 16.4 | |
| Lower phase | Control | 46.9 ± 8.2 | 29.1 ± 6.1 | 9.8 ± 1.6 | 4 ± 0.8 | 2.1 ± 0.3 | 1 ± 0.05 | 100 ± 17.9 | 100 ± 13.3 |
| Epinephrine | 34 ± 11 | 30.7 ± 10.1 | 7 ± 1 | 4.4 ± 1.2 | 1.6 ± 0.3 | 0.8 ± 0.05 | 159 ± 49.7 | 94.1 ± 35.2 | |
| Total matrix | Control | 31.1 ± 4.5 | 24.9 ± 4.3 | 8.1 ± 0.5 | 3.8 ± 0.5 | 2 ± 0.6 | 1.4 ± 0.2 | 100 ± 30.5 | 100 ± 8 |
| Epinephrine | 28.6 ± 6.1 | 23.5 ± 3.7 | 7.3 ± 2 | 3.3 ± 0.5 | 1.6 ± 0.3 | 1.3 ± 0.2 | 116.2 ± 33.9 | 127.6 ± 13.9 | |
Standard deviations are marked as variations of parameters. Green indicates significant differences (t-test for paired samples, p < 0.05).
Changes in M. luteus C01 biofilm matrix protein concentrations in the presence of 4.9 × 10–9 M epinephrine after 24 h of incubation in comparison with control.
| No | Accession | Protein name | Fold change | Mol. weight (kDa) | MS/MS count |
| 1 |
| Inositol-1-monophosphatase | 6.61 | 31.378 | 14 |
| 2 |
| Glutaredoxin domain-containing protein | 5.85 | 18.144 | 6 |
| 3 |
| Type 1 glutamine amidotransferase domain-containing protein | 3.04 | 24.132 | 35 |
| 4 |
| Peptidase S8 | 2.92 | 64.195 | 433 |
| 5 |
| Uncharacterized protein | 2.70 | 20.15 | 35 |
| 6 |
| Preprotein translocase subunit YajC | 2.64 | 15.163 | 86 |
| 7 |
| LysM peptidoglycan-binding domain-containing protein | 2.60 | 71.408 | 33 |
| 8 |
| Probable cytosol aminopeptidase | 2.50 | 54.491 | 36 |
| 9 |
| MBL fold metallohydrolase | 2.49 | 24.133 | 20 |
| 10 |
| Phage shock protein A (PspA) family protein | 2.11 | 29.31 | 81 |
| 11 |
| Non-specific serine/threonine protein kinase | 2.03 | 71.123 | 62 |
| 12 |
| Amidohydrolase, imidazolonepropionase | 2.03 | 43.201 | 86 |
| 13 |
| SSD domain-containing protein | 2.00 | 113.59 | 293 |
| 14 |
| Phosphate-binding protein PstS | 1.89 | 38.326 | 280 |
| 15 |
| ATP-dependent Clp protease proteolytic subunit | 1.89 | 24.332 | 8 |
| 16 |
| Multisubunit Na+/H+ antiporter, MnhC subunit | 1.87 | 15.009 | 29 |
| 17 |
| Peptidase | 1.83 | 101.19 | 374 |
| 18 |
| NDP-hexose 4-ketoreductase | 1.81 | 93.374 | 137 |
| 19 |
| Triosephosphate isomerase | 1.79 | 27.48 | 40 |
| 20 |
| ABC transporter substrate-binding protein | 1.68 | 38.056 | 39 |
| 21 |
| Uncharacterized protein | 1.65 | 32.171 | 351 |
| 22 |
| ABC transporter substrate-binding protein | 1.48 | 60.578 | 412 |
| 23 |
| MFS transporter (fragment) | 0.69 | 51.295 | 35 |
| 24 |
| Uncharacterized protein | 0.61 | 53.742 | 183 |
| 25 |
| Acyltransferase | 0.59 | 26.765 | 13 |
| 26 |
| 1-Deoxy- | 0.55 | 71.346 | 23 |
| 27 |
| Coenzyme A biosynthesis bifunctional protein CoaBC | 0.54 | 43.718 | 9 |
| 28 |
| Cysteine synthase | 0.54 | 32.51 | 23 |
| 29 |
| DNA/RNA helicase, superfamily II | 0.51 | 65.708 | 71 |
| 30 |
| ABC transporter ATP-binding protein | 0.49 | 65.461 | 42 |
| 31 |
| 1-Acyl-sn-glycerol-3-phosphate acyltransferase | 0.48 | 25.501 | 39 |
| 32 |
| Uncharacterized protein | 0.46 | 62.278 | 44 |
| 33 |
| Ribonucleoside-diphosphate reductase subunit beta | 0.44 | 37.516 | 109 |
| 34 |
| Metallophosphoesterase | 0.43 | 33.418 | 45 |
| 35 |
| Glycine dehydrogenase (decarboxylating) | 0.41 | 104.08 | 179 |
| 36 |
| Nucleoside diphosphate kinase | 0.39 | 15.291 | 73 |
| 37 |
| 50S ribosomal protein | 0.37 | 12.961 | 27 |
| 38 |
| Thymidine phosphorylase | 0.37 | 46.184 | 10 |
| 39 |
| Citrate synthase | 0.36 | 48.148 | 54 |
| 40 |
| M13 family peptidase | 0.36 | 75.904 | 46 |
| 41 |
| Hydrolase | 0.36 | 44.192 | 5 |
| 42 |
| Signal recognition particle protein | 0.33 | 56.531 | 47 |
| 43 |
| Spectinomycin tetracycline efflux pump | 0.32 | 51.017 | 11 |
| 44 |
| Alanine aminopeptidase | 0.30 | 96.24 | 78 |
| 45 |
| Isoleucine–tRNA ligase | 0.27 | 125.71 | 44 |
| 46 |
| Cytokinin riboside 5-monophosphate phosphoribohydrolase | 0.25 | 28.048 | 12 |
| 47 |
| IMP dehydrogenase | 0.23 | 37.348 | 31 |
| 48 |
| Methylmalonate-semialdehyde dehydrogenase [acylating] | 0.21 | 53.7 | 140 |
| 49 |
| Beta-(1–>2)glucan export ATP-binding/permease protein NdvA | 0.20 | 9.0263 | 12 |
| 50 |
| 2,3-Butanediol dehydrogenase, R-alcohol forming, (R)-and (S)-acetoin-specific | 0.17 | 37.876 | 34 |
| 51 |
| Uncharacterized protein | 0.16 | 31.627 | 13 |
| 52 |
| SNARE-like domain protein | 0.14 | 23.382 | 6 |
| 53 |
| Copper (Cu(I)) transporter ATPase | 0.09 | 84.519 | 8 |
Light green—increase in concentration; dark pink—decrease in concentration.
Changes in M. luteus C01 biofilm matrix protein concentrations in the presence of 4.9 × 10–9 M epinephrine after 72 h of incubation in comparison with control.
| Accession | Protein name | Fold change | Mol. weight (kDa) | MS/MS count |
|
| DNA protection during starvation protein | 25.51 | 22.266 | 10 |
|
| Methylmalonate-semialdehyde dehydrogenase (acylating) | 20.11 | 53.7 | 140 |
|
| Agmatinase | 19.87 | 35.919 | 36 |
|
| Phage holin family protein | 15.57 | 16.423 | 40 |
|
| 50S ribosomal protein L18 | 11.89 | 12.961 | 27 |
|
| S-adenosylmethionine synthase | 10.50 | 44.787 | 108 |
|
| Hydrolase, alpha/beta domain protein | 9.93 | 30.406 | 22 |
|
| Manganese transport protein MntH | 3.87 | 48.117 | 49 |
|
| Uncharacterized protein | 3.65 | 14.661 | 66 |
|
| Daunorubicin/doxorubicin resistance ATP-binding protein DrrA | 3.38 | 29.108 | 127 |
|
| Sodium:proton antiporter | 0.53 | 11.837 | 44 |
|
| Histidine kinase | 0.45 | 64.426 | 51 |
Light green—increased concentration due to biofilm maturation; dark green—increased concentration in the presence of epinephrine; dark orange—downregulation caused by epinephrine.
Lipids detected in M. luteus C01 biofilm matrix.
| Component | Control 24 h | Control 72 h | Epinephrine 24 h | Epinephrine 72 h | ||||
|
|
|
|
| |||||
| Abs | % | Abs | % | Abs | % | Abs | % | |
| Diphosphatidylglycerol | 1.75 | 0.05 | 0 | 0 | 0 | 0 | 0 | 0 |
| Phosphatidylglycerol | 11.58 | 0.33 | 0 | 0 | 0 | 0 | 0 | 0 |
| Unidentified phospholipid | 4.77 | ? | 0 | 0 | 0 | 0 | 0 | 0 |
| Unidentified polar lipid 1 | 15.65 | ? | 0 | 0 | 0 | 0 | 0 | 0 |
| Unidentified polar lipid 2 | 14.11 | ? | 3.86 | ? | 0 | 0 | 4.4 | ? |
| Unidentified glycolipid | 39.77 | ? | 8.82 | ? | 5.51 | ? | 14.61 | ? |
| Sterols | 12.05 | 0.44 | 3.76 | 0.11 | 4.12 | 0.13 | 7.26 | 0.16 |
| Sterol esters | 11.15 | 0.41 | 4.82 | 0.14 | 2.58 | 0.08 | 12.91 | 0.29 |
| Diacylglycerols | 16.48 | 0.55 | 7.59 | 0.2 | 6.47 | 0.19 | 12.01 | 0.25 |
| Triacylglycerols | 12.14 | 0.48 | 6.17 | 0.19 | 4.84 | 0.17 | 4.75 | 0.119 |
| Free fatty acids | 36.41 | 1.22 | 10.55 | 0.28 | 17.37 | 0.5 | 15.54 | 0.327 |
| Monoacylglycerols | 33.24 | 1.04 | 8.1 | 0.2 | 14.47 | 0.39 | 20.84 | 0.4 |
| Total | 209.14 | 4.52 (?) | 53.68 | 1.11 (?) | 55.38 | 1.452 (?) | 92.33 | 1.53 (?) |
FIGURE 3SERS spectra of M. luteus C01 biofilms. (A) Upper phase of the matrix. (B) Lower phase of the matrix. (C) Intact biomass. (D) Biomass after matrix extraction. (E) Principal component analysis of SERS spectra for 72 h samples (CC, control cells; CA, epinephrine-treated cells; MUC, control upper phase of the matrix; MUA, epinephrine-treated upper phase of the matrix; MLC, control lower phase of the matrix; MLA, epinephrine-treated lower phase of the matrix).
FIGURE 4Parts of the 2D 1H,13C edHSQC spectrum of M. luteus C01 matrix polysaccharides [24 h (control)] eluted in 0.1 M phosphate buffer. The corresponding parts of the 1H and 13C NMR spectra are shown along the horizontal and vertical axes, respectively. Numbers refer to protons and carbons of sugar units designated by the letters shown in Table 5.
FIGURE 5Parts of the 2D ROESY spectrum of M. luteus C01 matrix polysaccharides [24 h (control)] eluted in 0.1 M phosphate buffer measured in a 9: 1 H2O/D2O mixture. The corresponding parts of the 1H NMR spectra are shown along the horizontal and vertical axes, respectively. Numbers refer to the protons and carbons of sugar units designated by the letters shown in Table 5.
1H and 13C NMR chemical shifts in cell wall polysaccharides of M. luteus C01 (δ, ppm).
| Residue | C-1 | C-2 | C-3 | C-4 | C-5 | C-6 | Fit |
| PSI | GOF 0.79, RMS 1.27, LC 1.000 | ||||||
| HOOC-CH-CH2-CH2-COOH Glu | 176.4 | 55.5 | 28.5 | 31.7 | 178.0 | ||
|
| |||||||
| 6) | 101.5 | 54.6 | 74.1 | 73.6 | 76.5 | 170.6 | |
|
| |||||||
| →6)-α-Glc | 98.3 | 55.0 | 71.8 | 70.8 | 72.1 | 69.3 | |
|
| |||||||
| PSII | GOF 0.27, RMS 0.38, LC 1.000 | ||||||
|
| |||||||
| →6)-α-Man | 103.6 | 71.3 | 72.0 | 67.4 | 72.7 | 66.2 | |
|
| |||||||
| →2)-α-Man | 101.7 | 79.3 | 71.5 | 68.3 | 74.6 | 62.3 | |
|
| |||||||
| →3)-α-Man | 100.9 | 70.9 | 78.5 | 67.8 | 74.1 | 61.8 | |
|
| |||||||
| PSIII/PSIII’ | GOF 0.65 RMS 1.34, LC 1.000 (PSIII) | ||||||
|
| |||||||
| →4)-β-D-Glc | 101.3 | 56.8 | 73.2 | 81.3 | 76.6 | 61.1 | |
|
| |||||||
| →4)-β-D-Glc | 102.1 | 57.3 | 74.4 | 78.9 | 75.6 | 61.8 | |
|
| |||||||
| →4)-β-D-Glc | 103.4 | 55.9 | 78.8 | 76.7 | 76.3 | 61.1 | |
|
| |||||||
| →4)-β-D-Glc | 100.3 | 57.0 | 77.2 | 76.0 | 76.9 | 62.3 | |
|
| |||||||
| R-Lac-(2→ R | 182.6 | 80.6 | 19.7 | ||||
|
| |||||||
| R-Lac(2→ R’ | 175.8 | 75.9 | 18.0 | ||||
|
| |||||||
| PSIV | GOF 0.23 RMS 0.31, LC 1.000 | ||||||
|
| |||||||
| →2)-β-Man | 101.6 | 79.1 | 73.3 | 68.1 | 77.7 | ||
|
| |||||||
| →4)-β-Man | 101.4 | 71.4 | 72.8 | 78.1 | 76.4 | ||
|
| |||||||
| →4)-β-Glc | 104.3 | 74.4 | 75.2 | 79.6 | 76.3 | ||
|
| |||||||
| PSIII/PSIII’ Smith | |||||||
|
| |||||||
| →4)-β-D-Glc | 101.3 | 56.9 | 73.4 | 81.3 | 76.6 | 61.9 | |
|
| |||||||
| →4)-β-D-Glc | 102.0 | 57.4 | 72.8 | 79.2 | 75.7 | 61.9 | |
|
| |||||||
| →4)-β-D-Glc | 103.4 | 56.0 | 79.4 | 76.7 | 76.2 | 61.1 | |
|
| |||||||
| →4)-β-D-Glc | 98.9 | 57.8 | 78.9 | 76.9 | 76.8 | 61.1 | |
|
| |||||||
| R-Lac-(2→ R | 181.6 | 79.9 | 19.8 | ||||
|
| |||||||
| R-Lac-(2→ R’ | 182.1 | 81.3 | 18.9 | ||||
CH3CON (A) at δH 2.09, δC 23.4 and 176.8.
CH3CON (B) at δH 2.05, δC 23.4 and 175.6.
CH3CON (F) at δH 2.02, δC 23.5 and 175.9.
CH3CON (G) at δH 2.04, δC 23.5 and 175.9.
aThe assignment of the unsubstituted –CH2OH groups (C-6 of hexoses) was performed tentatively in a range of δ 61.1–62.3 ppm and adjusted from calculations.
bResults for PSIII’ are provided from a simulation with muramic acid and N-acetyl-glucosamine used as a monomeric composition.
cFor the simulation of PSIV, an average value of 62.2 ppm was used for all C-6 chemical shifts.
Correlations for H-1 and C-1 in the 2D ROESY and 1H,13C HMBC spectra of the 24 h (control) matrix polysaccharides of M. luteus C01.
| Anomeric atom in sugar residue (δ) | Correlation(s) to atoms in sugar residue(s) (δ) | |
|
| ||
| ROESY | HMBC | |
|
| ||
|
| ||
|
| ||
|
| ||
|
| ||
FIGURE 6Structure of M. luteus C01 cell wall polysaccharide.